PRO1271 Polypeptides

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S300000, C530S866000, C530S402000

Reexamination Certificate

active

07345146

ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 2003/0096951 (2003-05-01), Jacobs et al.
patent: WO 99/63088 (1999-12-01), None
Ma et.al., Proc. Natl. Acad. Sci. USA 98:9778-9783, 2001.
Sen, Curr. Opin. Oncol. 12:82 88, 2000.
Haynes et al., Electrophoresis 19:1862-1871, 1998.
Bork, A. Genome Res. 10:398-400, 2000.
Skolnick et al., 18(1):34-39, 2000.
Doerks et al., Trends in Genetics 14(6):248-250 1998.
Smith et al., Nature Biotech. 15:1222-1223, 1997.
Brenner, S.E., Trends in Genetics. 15(4):132-133, 1999.
Bork et al., Trends in Genetics. 12(10):425-427, 1996.
Wells, J.A. Biochemistry. 29(37):8509-8517, 1990.
Ngo et al. Computational complexity, protein structure prediction, and the Levinthal paradox. In Merz and Le Grand (Eds.) The Protein Folding Problem and Tertiary Structure Prediction. Birkhauser-Boston, pp. 492-495, 1994.
Pennica et al., Proc. Natl. Acad. Sci. USA. 95(25):14717-14722, 1998.
Bustin et al., TRENDS in Molec. Med. 8(6): 269-272, 2002.
Hu et al., J. Proteome Research 2:405-412, 2003.
Saito-Hisaminato et al., DNA Res., 9:35-45, 2002.
Genes VI, Benjamin Lewin, 1997, excert from chapter 29 (includes pp. 847-848).
Madoz-Gurpide et al., Adv. Exp. Med. Biol., vol. 532: 51-58, 2003.
Lilley et al. (“Proteomics” Molecular Biology in Cellular Pathology, (2003) England: John Wiley & Sons, pp. 351-352).
Wildsmith et al. (Gene Expression Analysis Using Microarrays Molecular Biology in Cellular Pathology, (2003) England: John Wiley & Sons, pp. 269-286.
Nagaraja et al., Oncogene, 25: 2328-2338, 2006.
Waghray et al., Proteomics, 1:1327-1338, 2001.
Sagynaliev et al., Proteomics, 5: 3066-3078, 2005.
King et al., JAMA 286: 2280-2288, 2001.
Greenbaum et al., Genome Biology, vol. 4, Issue 9, pp. 117.1-117.8, 2003.
Anderson et al., Electrophoresis, vol. 18, pp. 533-537, 1997.
Fessler et al., J. Biol. Chem. 277: 31291-31302.
Lian et al., Blood 98 : 513-524, 2001.
Klein et al. Selection for Genes Encoding Secreted Proteins and Receptors.Proc. Natl. Acad. Sci., 93:7108-7113 (1996).
Hedge et al., “A Concise Guide to cDNA Microarray Analysis”, BioTechniques, vol. 29, No. 3, pp. 548-562, Sep. 2000.
Hong et al., “An Autoantibody-Mediated Immune Response to Calreticulin Isoforms in Pancreatic Cancer”, Cancer Research, vol. 64, pp. 5504-5510, Aug. 1, 2004.
Kiss et al., “Polymorphisms of Glutathione-S-Transferase and Arylamine N-Acetyltransferase Enzymes and Susceptibility to Colorectal Cancer”, Anticancer Research, vol. 24, pp. 3965-3970, 2004.
Nagao et al., “Identification and characterization of multiple isoforms of a murine and human tumor suppressor;patched, having distinct first exons”, Genomics, vol. 85, pp. 462-471, 2005.
Peng et al., “A Novel RARβ Isoform Directed by a Promoter P3 and Mediated by Retionic Acid in Breast Cancer Cells”, Cancer Research, vol. 64, pp. 8911-8918, Dec. 15, 2004.
Perego et al., N-and C- terminal isoforms of arg quantified by real-time PCR are specifically expressed in human normal and neoplastic cells, in neoplastic cell lines, and in HL-60 cell differentiation”, Molecular Carcinogenesis vol. 42, Issue 4, pp. 229-239, Mar. 11, 2005.
Quackenbush, J., “Microarray Data Normalization and Transformation,”Nature Genetics Supplement—32:496-501 (2002).
Dayhoff, Accession No. P—AAB50924, WO 200073452-A2, Pub Date: Dec. 7, 2000, A. J. Ashkenazi et al.
Dayhoff, Accession No. P—AAB65284, WO 200073454-A1, Pub Date: Dec. 7, 2000, A. J. Ashkenazi et al.
Dayhoff, Accession No. P—AAB88375, EP 1067182-A2, Pub Date: Jan. 10, 2001, T. Ota et al.
Dayhoff, Accession No. P—AAE01725, WO 200134767-A2, Pub Date: May 17, 2001, Dr. Soppet et al.
Dayhoff, Accession No. P—AAE01724, WO 200134767-A2, Pub Date: May 17, 2001, Dr. Soppet et al.
Dayhoff, Accession No. P—AAE01723, WO 200134767-A2, Pub Date: May 17, 2001, Dr. Soppet et al.
Dayhoff, Accession No. P—AAE01683, WO 200134767-A2, Pub Date: May 17, 2001, Dr. Soppet et al.
Dayhoff, Accession No. P—AAE03766, WO 200132837-A1, Pub Date: May 10, 2001, M. Fiscella et al.
Dayhoff, Accession No. P—AAE06585, WO 200149728-A2, Pub Date: Jul. 12, 2001, S. Kato et al.
Dayhoff, Accession No. P—AAU14891, WO 200155442-A2, Pub Date: Aug. 2, 2001, J. E. Ford et al.
Dayhoff, Accession No. P—AAU12426, WO 200140466-A2, Pub Date: Jun. 7, 2001, K. P. Baker et al.
Dayhoff, Accession No. P—AAY66761, WO 9963088-A2, Pub Date: Dec. 9, 1999, K. Baker et al.
Dayhoff, Accession No. P—AAY94908, WO 200009552-A1, Pub Date: Feb. 24, 2000, K. Jacobs et al.
Dayhoff, Accession No. CAC51159.1, WO 0149728-A5, Pub Date: Jul. 12, 2001, S. Kato et al.
Dayhoff, Accession No. CAC39740.1, EP 1067182-A1, Pub Date: Jan. 10, 2001, T. Ota et al.
Dayhoff, Accession No. P—AAG81329, WO 200129221-A2, Pub Date: Apr. 26, 2001, D. C. Conklin et al.
Dayhoff, Accession No. CAC38579.1, WO 0129221-A1, Pub Date: Apr. 26, 2001, D. C. Conklin et al.
Dayhoff, Accession No. AAG21694.1, Direct Submission, Submitted: Sep. 20, 2000, F. Ma et al.
Dayhoff, Accession No. NP—443164.1, Proc. Natl. Acad. Sci. U.S. A. 98 (17), 9778-9783, 2001, F. Ma et al.
Dayhoff, Accession No. P—AAU14973, WO 200155442-A2, Aug. 2, 2001, J. E. Ford et al.
GenBank, Accession No. P—AAF44253, WO 200073454-A1, Pub Date: Dec. 7, 2000, A. J. Ashkenazi et al.
GenBank, Accession No. P—AAC91483, WO 200073452-A2, Pub Date: Dec. 7, 2000, A. J. Ashkenazi et al.
GenBank, Accession No. P—AAS21498, WO 200140466-A2, Pub Date: Jun. 7, 2001, K. P. Baker et al.
GenBank, Accession No. P—AAZ65107, WO 9963088-A2, Pub Date: Dec. 9, 1999, K. P. Baker et al.
GenBank, Accession No. AX055461, WO 0073452-A, Pub Date: Dec. 7, 2000, A. J. Ashkenazi et al.
GenBank, Accession No. P—AAF93802, EP 1067182-A2, Pub Date: Jan. 10, 2001, T. Ota et al.
GenBank, Accession No. AX136195, EP 1067182-A, Pub Date: Jan. 10, 2001, T. Ota et al.
GenBank, Accession No. P—AAD12580, WO 0073348-A, Pub Date: Jul. 12, 2001, S. Kato et al.
GenBank, Accession No. AX191533, WO 200149728-A2, Pub Date: Jul. 12, 2001, S. Kato et al.
GenBank, Accession No. P—AAA16628, WO 200009552-A1, Pub Date: Feb. 24, 2000, K. Jacobs et al.
GenBank, Accession No. XM—055369.
GenBank, Accession No. P—AAS23196, WO 200155442-A2, Pub Date: Aug. 2, 2001, J. E. Ford et al.
GenBank, Accession No. P—AAD05545, WO 200134767-A2, Pub Date: May 17, 2001, D. R. Soppet et al.
GenBank, Accession No. P—AAD08193, WO 200132837-A1, Pub Date: May 10, 2001, M. Fiscella et al.
GenBank, Accession No. P—AAD05544, WO 200134767-A2, Pub Date: May 17, 2001, D. R. Soppet et al.
GenBank, Accession No. P—AAD05503, WO 200134767-A2, Pub Date: May 17, 2001, D. R. Soppet et al.
GenBank, Accession No. P—AAD05543, WO 200134767-A2, Pub Date: May 17, 2001, D. R. Soppet et al.
GenBank, Accession No. AY008283, Direct Submission, Submitted: Sep. 20, 2000, F. Ma et al.
GenBank, Accession No. NM—052932, Proc. Natl. Acad. Sci. U.S. A., 98 (17), 9778-9783, 2001, F. Ma et al.
Golub, T.R., et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring,”Science—285:531-537 (1999).
Wen, W., et al., “Comparison ofTP53Mutations Identified by Oligonucleotide Microarray and Conventional DNA Sequence Analysis1,”Cancer Research—60:2716-2722 (2000).
MAQC Consortium, “The MicroArray Quality Control (MAQC) Project Shows Inter- and Intraplatorm Reproduc

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

PRO1271 Polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with PRO1271 Polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRO1271 Polypeptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2809498

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.